E-cadherin is one of the major tumor suppressors in GC and the structural modifications in its encoding gene CDH1 or alterations in its expression have been found as the common events that suppress the broad-ranging functions of E-cadherin during cancer progression and contribute to the morphogenetic effects in cancer [10,28,61]. The gene discussed is CDH1; the disease is neoplasm.